BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 7858159)

  • 1. Pathological Tau proteins of Alzheimer's disease as a biochemical marker of neurofibrillary degeneration.
    Delacourte A
    Biomed Pharmacother; 1994; 48(7):287-95. PubMed ID: 7858159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurofibrillary degeneration in amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam. Immunochemical characterization of tau proteins.
    Buée-Scherrer V; Buée L; Hof PR; Leveugle B; Gilles C; Loerzel AJ; Perl DP; Delacourte A
    Am J Pathol; 1995 Apr; 146(4):924-32. PubMed ID: 7717459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ubiquitination and abnormal phosphorylation of paired helical filaments in Alzheimer's disease.
    Iqbal K; Grundke-Iqbal I
    Mol Neurobiol; 1991; 5(2-4):399-410. PubMed ID: 1726645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tau protein and the neurofibrillary pathology of Alzheimer's disease.
    Goedert M
    Ann N Y Acad Sci; 1996 Jan; 777():121-31. PubMed ID: 8624074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different distribution of phosphorylated tau protein isoforms in Alzheimer's and Pick's diseases.
    Sergeant N; David JP; Lefranc D; Vermersch P; Wattez A; Delacourte A
    FEBS Lett; 1997 Aug; 412(3):578-82. PubMed ID: 9276470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurodegeneration and plasticity.
    Arendt T
    Int J Dev Neurosci; 2004 Nov; 22(7):507-14. PubMed ID: 15465280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Senile dementia of Lewy body type and Alzheimer type are biochemically distinct in terms of paired helical filaments and hyperphosphorylated tau protein.
    Harrington CR; Perry RH; Perry EK; Hurt J; McKeith IG; Roth M; Wischik CM
    Dementia; 1994; 5(5):215-28. PubMed ID: 7951676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granular tau oligomers as intermediates of tau filaments.
    Maeda S; Sahara N; Saito Y; Murayama M; Yoshiike Y; Kim H; Miyasaka T; Murayama S; Ikai A; Takashima A
    Biochemistry; 2007 Mar; 46(12):3856-61. PubMed ID: 17338548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of aluminum with paired helical filament tau is involved in neurofibrillary pathology of Alzheimer's disease.
    Shin RW
    Gerontology; 1997; 43 Suppl 1():16-23. PubMed ID: 9187935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational change as one of the earliest alterations of tau in Alzheimer's disease.
    Weaver CL; Espinoza M; Kress Y; Davies P
    Neurobiol Aging; 2000; 21(5):719-27. PubMed ID: 11016541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological proteins Tau 64 and 69 are specifically expressed in the somatodendritic domain of the degenerating cortical neurons during Alzheimer's disease. Demonstration with a panel of antibodies against Tau proteins.
    Delacourte A; Flament S; Dibe EM; Hublau P; Sablonnière B; Hémon B; Shérrer V; Défossez A
    Acta Neuropathol; 1990; 80(2):111-7. PubMed ID: 2117840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tau protein and the neurofibrillary pathology of Alzheimer's disease.
    Goedert M
    Trends Neurosci; 1993 Nov; 16(11):460-5. PubMed ID: 7507619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical and molecular characterization of neurofibrillary degeneration in frontotemporal dementias.
    Delacourte A
    Dement Geriatr Cogn Disord; 1999; 10 Suppl 1():75-9. PubMed ID: 10436346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of specific sets of tau isoforms reflects different neurofibrillary degeneration processes.
    Mailliot C; Sergeant N; Bussière T; Caillet-Boudin ML; Delacourte A; Buée L
    FEBS Lett; 1998 Aug; 433(3):201-4. PubMed ID: 9744794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular dissection of the neurofibrillary lesions of Alzheimer's disease.
    Goedert M
    Arzneimittelforschung; 1995 Mar; 45(3A):403-9. PubMed ID: 7763334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plaque biogenesis in brain aging and Alzheimer's disease. I. Progressive changes in phosphorylation states of paired helical filaments and neurofilaments.
    Su JH; Cummings BJ; Cotman CW
    Brain Res; 1996 Nov; 739(1-2):79-87. PubMed ID: 8955927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transglutaminase bonds in neurofibrillary tangles and paired helical filament tau early in Alzheimer's disease.
    Singer SM; Zainelli GM; Norlund MA; Lee JM; Muma NA
    Neurochem Int; 2002 Jan; 40(1):17-30. PubMed ID: 11738469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and anatomical redistribution of tau protein in Alzheimer's disease.
    Mukaetova-Ladinska EB; Harrington CR; Roth M; Wischik CM
    Am J Pathol; 1993 Aug; 143(2):565-78. PubMed ID: 8342603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathology of the neuronal cytoskeleton in Alzheimer's disease.
    Brion JP
    Biochim Biophys Acta; 1992 Nov; 1160(1):134-42. PubMed ID: 1384716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease.
    Delacourte A; David JP; Sergeant N; Buée L; Wattez A; Vermersch P; Ghozali F; Fallet-Bianco C; Pasquier F; Lebert F; Petit H; Di Menza C
    Neurology; 1999 Apr; 52(6):1158-65. PubMed ID: 10214737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.